* Andersen RF et al. (2012) Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome. Proteomics Clin Appl. 6(7-8):382-93*Saleh AAW et al. (2014) Markers of Inflammation and Thrombophilia in Psoriasis. Med. J. Cairo Univ. 82(1):127-131*Sehgal A et al. (2015) An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia. Nature Medicine 21(5):492-497* Nair JK et al. (2017) Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc?siRNA conjugates. Nucleic Acids Res. 45(19):10969-10977. doi: 10.1093/nar/gkx818* Schochl H et al. (2017) Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis. Critical Care. 21(1):51* Selmeczi A et al. (2017) Antithrombin Debrecen (p. Leu205Pro)?Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency. Thromb Res. 158:1-7* Chan KC et al. (2019) Astaxanthin attenuated thrombotic risk factors in type 2 diabetic patients. Journal of Functional Foods. 53:22-27* Premkumar M et al. (2019) Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute?on?chronic liver failure: An observational cohort study. Liver Int. 39(4):694-704